Intermediate Antiparallel β Structure in Amyloid β Plaques Revealed by Infrared Spectroscopic Imaging

Area of Science:

• Neuroscience
• Biochemistry
• Medical Imaging

Background:

• Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) plaques.
• In vitro studies show mature amyloid fibrils have parallel beta-sheet structures.
• Intermediate structures, like antiparallel beta-sheets, may form during aggregation but their presence in AD plaques is unknown.

Purpose of the Study:

• To investigate the presence and structure of amyloid aggregates within AD brain plaques.
• To bridge the gap between in vitro amyloid structure studies and ex vivo AD pathology.
• To determine if intermediate beta-sheet structures exist in amyloid plaques.

Main Methods:

• Utilized infrared (IR) imaging to spatially localize and analyze protein structures within individual amyloid plaques in AD tissues.
• Applied IR spectroscopy for molecular sensitivity to probe protein structural distributions.
• Validated findings by comparing IR imaging of ex vivo plaques with in vitro amyloid aggregates.

Main Results:

• Demonstrated that fibrillar amyloid plaques in AD tissues exhibit antiparallel beta-sheet signatures.
• Provided direct evidence connecting in vitro observed structures to amyloid aggregates in the human brain.
• Confirmed antiparallel beta-sheet structure as a distinct feature of amyloid fibrils using IR imaging.

Conclusions:

• Amyloid plaques in Alzheimer's disease brains contain antiparallel beta-sheet structures.
• IR imaging is a viable technique for analyzing protein structures in ex vivo AD tissues.
• Findings establish a direct link between in vitro amyloid fibril structures and AD pathology.